Abstract. Technology for minimally invasive approaches to congenital heart disease is a rapidly evolving field. This case report reviews a novel approach to combining two of the newer technologies available to treat a pediatric patient with an atrial septal defect (ASD) and a vascular ring. This report is the first to describe the use of the da Vinci surgical system to assist in a thoracoscopic procedure for a pediatric patient. The da Vinci assisted division of the vascular ring, joined with an Amplatzer closure of the ASD, demonstrates how maximum benefit can be obtained for patients by combining emerging technologies.
A 6-year-old male presented to the C. S. Mott Children's Hospital at the University of Michigan with a diagnosis of a secundum-type atrial septal defect (ASD) and a vascular ring consisting of a right aortic arch with left ligamentum arteriosus. He was recently diagnosed after work up for a murmur noted on physical exam. His mother reported that he occasionally needed to stop strenuous activity for ''shortness of breath,'' thought to be due to reactive airway disease. He denied any stridor, wheezing, or dysphagia. His previous medical history was significant only for the diagnosis of reactive airway disease. He was on no scheduled medications.
Physical exam revealed a healthy-appearing young male in no distress. Pertinent findings included clear and equal breath sounds bilaterally. There was a normal S1 and fixed, split S2 with a grade II/VI systolic ejection murmur at the left upper sternal border. Chest radiograph showed mild cardiomegaly with slightly increased pulmonary vascular markings and a right aortic arch. Doppler/echocardiogram demonstrated a 6.5-mm secundum-type ASD and a right aortic arch with aberrant left subclavian artery. Computed tomography of the chest confirmed the vascular ring consisting of a right aortic arch with an aberrant left subclavian artery arising from a Kommerell's diverticulum (Fig. 1) .
The patient was admitted to the pediatric cardiology service, at which time he under went closure of his ASD with an Amplatzer septal occluder (AGA Medical, Golden Valley, MN, USA) ( Fig. 2) . Postprocedure transesophageal Doppler/echocardiography revealed no significant residual shunting (Fig. 3) . The following day, the patient was taken to the operating room and placed in a right lateral decubitus position. A bronchial blocker was employed for single right lung ventilation to assist in exposure. The division of the left ligamentum arteriosus was performed using the da Vinci surgical system (Intuitive Surgical, Sunnyvale, CA, USA) via four ports (Fig. 4) . The ports included a 12-mm port for the camera, a 10-mm port for a lung retractor, and 2 to 8-mm ports for the operating instruments. The ligamentum arteriosus was circumferentially mobilized, clipped with an endoscopic clip applier in case of residual patency, and divided. Fibrous bands around the esophagus and tracheal were divided, and a small Kommerell's diverticulum was mobilized. The patient had an unremarkable post operative course and was discharged on postoperative day 2.
Discussion
Technologies for minimally invasive therapy are a rapidly growing segment of the field of congenital heart disease. A simple MEDLINE search for minimally invasive cardiac or thoracic surgery manuscripts reveals more than 1000 citations for 2001-2002 alone. The goals of these techniques are to safely decrease morbidity, cost, patient discomfort, and length of convalescence with improved patient satisfaction and cosmetic result. Two of the newer techniques available are the use of the Amplatzer septal occluder for catheter-based closure of (ASDs) and the da Vinci surgical system, which is an operative robot to assist in minimally invasive procedures.
The Amplatzer has been used with excellent success for the closure of ASD. Dong and associates [1] , in a multinstitutional study comparing transcatheter and surgical closure of ASD, found a 95.7% success rate for device closure compared to 100% for surgery (p = 0.006). The rate of major complication, not including failure of closure, was 1.6% (7/442) for device closure and 5.4% (8/154) for the surgical group (p = 0.03). Mean length of stay was 1.0 ± 0.3 days for the device group and 3.4 ± 1.2 days for the surgery group (p < 0.001). A similar decrease in length of stay was demonstrated by Hughes and colleagues [2] in a prospective study comparing 43 children who underwent Amplatzer device closure and 19 who underwent surgery. They found median hospital stays to be 88 hours (range, 78-112) compared to 29 hours (range, 28-30) for the surgical and device groups, respectively (p < 0.01). Although the median cost of the procedures was similar, total hospital costs were slightly higher for the surgical group at Aus $12,969 (range, $11,569-$14,215) compared to Aus $11,845 (range, $10,669-$12,555) (p = 0.03).
In adults, the use of the da Vinci system has been reported for several different applications, including lobectomy, resection or oversewing of bullae, lung and mediastinal tumor removal, and ASD closure [3] [4] [5] . This report is the first to describe the use of the da Vinci system to perform a pediatric cardiothoracic procedure, a division of a vascular ring. By combining this thoracoscopic procedure with a catheter-based closure of the ASD, the need for open-heart surgery and cardiopulmonary bypass was avoided.
